Cargando…

Characterization of Human CD39(+) Th17 Cells with Suppressor Activity and Modulation in Inflammatory Bowel Disease

Induced regulatory T-cells (iT-reg) and T helper type 17 (Th17) in the mouse share common CD4 progenitor cells and exhibit overlapping phenotypic and functional features. Here, we show that human Th17 cells endowed with suppressor activity (supTh17) can be derived following exposure of iT-reg popula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longhi, Maria Serena, Moss, Alan, Bai, Aiping, Wu, Yan, Huang, Huang, Cheifetz, Adam, Quintana, Francisco J., Robson, Simon C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914873/ https://www.ncbi.nlm.nih.gov/pubmed/24505337 http://dx.doi.org/10.1371/journal.pone.0087956

Ejemplares similares

NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine
por: Bai, Aiping, et al.
Publicado: (2015)

Author Correction: NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine
por: Bai, Aiping, et al.
Publicado: (2020)

Endogenous antisense RNA curbs CD39 expression in Crohn’s disease
por: Harshe, Rasika P., et al.
Publicado: (2020)

Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease
por: Vuerich, Marta, et al.
Publicado: (2022)

Barriers to Mesalamine Adherence in Patients with Inflammatory Bowel Disease: A Qualitative Analysis
por: Devlen, Jennifer, et al.
Publicado: (2014)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
por: Deyhim, Tina, et al.
Publicado: (2023)

The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis
por: Peng, Zhen‐Wei, et al.
Publicado: (2017)

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
por: Wilke, Cailin M, et al.
Publicado: (2011)

Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
por: Zhao, Junjun, et al.
Publicado: (2021)

The role of Th17 cells in inflammatory bowel disease and the research progress
por: Chen, Lu, et al.
Publicado: (2023)

Decreased Frequency of Intestinal CD39(+) γδ(+) T Cells With Tissue-Resident Memory Phenotype in Inflammatory Bowel Disease
por: Libera, Jana, et al.
Publicado: (2020)

Expansion in CD39(+) CD4(+) Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications
por: Leal, Fabio E., et al.
Publicado: (2013)

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
por: Owaga, Eddy, et al.
Publicado: (2015)

The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease
por: Yan, Jun-bin, et al.
Publicado: (2020)

CD39 and control of cellular immune responses
por: Dwyer, Karen M., et al.
Publicado: (2007)

BCL6 corepressor contributes to Th17 cell formation by inhibiting Th17 fate suppressors
por: Kotov, Jessica A., et al.
Publicado: (2019)

CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection
por: Yoshida, Osamu, et al.
Publicado: (2015)

39th Proceedings
por: Taylor, Peter J
Publicado: (1980)

CD39 pathway inhibits Th1 cell function in tuberculosis
por: Luo, Ying, et al.
Publicado: (2022)

JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease
por: Zhou, Rui, et al.
Publicado: (2017)

Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells
por: Elshal, Mohamed F., et al.
Publicado: (2015)

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
por: Kim, Yeon-Jeong, et al.
Publicado: (2015)

A primer on common supplements and dietary measures used by patients with inflammatory bowel disease
por: Minhas, Hadi J, et al.
Publicado: (2023)

Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease
por: Geng, Xianhui, et al.
Publicado: (2016)

Traditional Chinese Medicine Regulates Th17/Treg Balance in Treating Inflammatory Bowel Disease
por: Xie, Fengjiao, et al.
Publicado: (2022)

39th INTC Meeting
Publicado: (2011)

39th Convegno Nazionale
Publicado: (2010)

Role of CD34 in inflammatory bowel disease
por: Li, Zhiyuan, et al.
Publicado: (2023)

CD39(+ )Regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism
por: Ye, Zhi-Jian, et al.
Publicado: (2011)

CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)

Optimizing the use of biological therapy in patients with inflammatory bowel disease
por: Moss, Alan C.
Publicado: (2015)

Nephrolithiasis in patients with inflammatory bowel disease in the community
por: Cury, Dídia Bismara, et al.
Publicado: (2013)

Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice
por: De Giorgi, Marco, et al.
Publicado: (2017)

The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population
por: Medina, Tiago S., et al.
Publicado: (2023)

39th Meeting of the LHCb RRB
por: Elsen, E
Publicado: (2017)

39th session of CERN Council
Publicado: (1968)

39th Rencontres de Moriond
por: Tran Thanh Van, J.
Publicado: (2004)

39th Rencontres de Moriond
por: Chalabaev Almas, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_khtom0jcj9hn95nnahda702hq8